Risk model predicts response and survival of cancer patients treated with ICIs
Metastatic cancer is estimated to be responsible for 90% of cancer deaths
View ArticleDisrupted sleep could be associated with cognitive function changes
High amounts of disrupted sleep were found to affect memory and thinking performance
View ArticleOwkin and Evotec partner to accelerate therapeutics in oncology and I&I
The companies will aim to select targets, discover and develop new therapeutics
View ArticleImmune cell helps predict skin cancer patients’ responses to immunotherapies
Vd1-gd T cells were effective in predicting positive responses to ICI therapy
View ArticleAlcoChange app to help alcohol-related liver disease patients stay sober
Over a three-month period, 57% of patients using the app remained sober
View ArticleVicore Pharma’s DTx to benefit pulmonary fibrosis patients
The nine-week DTxl CBT helps to address psychological symptom burdens in PF patients
View ArticleDeepcell and NVIDIA collaborate to advance AI in single cell research
Both aim to advance the use of AI-powered cell analysis for cancer, stem cell and cell therapies
View ArticleFertilised chicken eggs could be viable for use in cancer imaging research
The fertilised eggs could cultivate tumours for imaging within seven days
View ArticleNew clinical study to advance development of treatments for liver cirrhosis
The £30m ADVANCE study is the most extensive study into liver disease worldwide
View ArticleBarinthus Bio announces $47m project to advance MERS coronavirus vaccine
The partnership will advance VTP-500 from early development to phase 2 clinical trials
View ArticleInhalable sensor to make lung cancer screening more accessible worldwide
The diagnostic system can deliver particles to the lungs via aerosol or a nebuliser
View ArticleNew data reveals out-of-hospital cardiac survival results remain low in England
In 2022, around 8% of patients survived 30 days after a cardiac arrest
View ArticleStudy reveals antibiotic use is not the only driver of antibiotic resistance
Researchers compared 20 years of antibiotic use on E. coli in the UK and Norway
View ArticleCambridge researchers begin new trial for oesophageal cancer screening
If successful, the new test could see routine screening introduced in the NHS
View ArticleKanabo and City Dock Pharmacy team up
Companies collaborate to launch walk-in pain clinic
View ArticleCellVoyant secures £7.6 million AI stem cell boost
CellVoyant’s platform combines AI with live cell imaging
View ArticleAston University receives £10m for membrane institute
Aston University to create the Aston Institute for Membrane Excellence
View ArticleDisco tunes into new cancer drug targets
EUR 20m to identify new targets and develop first in class drugs
View ArticlePoolbeg’s cytokine release syndrome drug shows potential
Data supports Poolbeg’s strategic expansion of POLB 001
View Article
